Toltrazuril sulfone sodium salt: synthesis, analytical detection, and pharmacokinetics in the horse.

The research studied the synthesis, analytical detection, and pharmacokinetics of a drug, Toltrazuril sulfone sodium salt, used to treat protozoal infections in horses. It concluded that the drug has good oral bioavailability and could be effectively administered with or without feed.

Synthesis of Toltrazuril Sulfone Sodium Salt

• The study began with the synthesis of Toltrazuril sulfone sodium salt, an antiprotozoal agent that is often used to treat equine protozoal myeloencephalomyelitis (EPM), a disease affecting the nervous system in horses.
• The scientists aimed to check the viability of this formulation as a treatment and preventive measure for EPM.

Analysis and Detection

• The research included the process of analytical detection of the synthesized compound,
• This step is essential to confirm the presence and purity of the synthesized compound.

Study of Pharmacokinetics

• The study involved the analysis of the pharmacokinetics, which is how the drug is absorbed, distributed, metabolized, and excreted in the horse’s body.
• The bioavailability of the drug, meaning the proportion of the drug which enters circulation and is able to have an active effect, was a key focus of the study.
• The results showed that the compound was rapidly absorbed, with a peak concentration arising 8 hours after administration. It has around 56% bioavailability as compared to intravenous administration of the same.

Comparison with Other Formulations

• The study also compared the bioavailability of toltrazuril sulfone suspended in water with that of toltrazuril sulfone sodium salt. The relative bioavailability was found to be 46%, meaning oral absorption of the drug was 54% less when suspended in water.

Usage as a Feed Additive

• The study also investigated whether this salt formulation of toltrazuril sulfone can be used as a feed additive without significant reduction in oral bioavailability.
• The researchers found that this formulation can be relatively well absorbed with food, with a mean oral bioavailability of 52%. Therefore, the drug can be effectively added to a horse’s feed for administration.

Conclusion

• After analyzing the data, the researchers concluded that repeated oral administration of toltrazuril sulfone sodium salt with or without feed can yield effective plasma and cerebrospinal fluid concentrations for the treatment and prophylaxis of EPM and other protozoal diseases.
• The research suggests that toltrazuril sulfone sodium salt has the potential to be used as a feed additive for both the treatment and prevention of EPM and other related diseases.